HealthChain Project: CardiacSense Revolutionizing Healthcare Monitoring Across Europe
March 26, 2024
Hundreds of millions of people worldwide suffer from hypertension, yet only a few have it under control. These people need constant monitoring.
Stay informed with our latest news
SOM small-sized system for flexibility of use
VS.
FDA Threshold
From Average of 24 participants
Sensitivity
96%
or higher
FDR
False Detection Rate
2%
or lower
Correlation coefficient
90%
or higher
Regression line slope
1± 0.02
PPV
Positive Predictive Value
80%
or higher
Bland-Altman 95% limits of agreement
Average
(±tolerance) ±
1.96*SD: 0 (±5) ± 100
Read more about our clinical trials that showed the CardiacSense watch to be as precise as ECG monitoring.